Yuvraj Singh underwent three cycles of chemotherapy in the US, and is expected to return to India in the first half of April Dr Nitesh Rohatgi a key member of Yuvraj’s medical team said. Yuvraj’s response to chemotherapy has left his medical team ‘fairly confident’ that the mediastinal seminoma he had been diagnosed with ‘will not come back.’ Dr Nitesh Rohatgi, a key member of Yuvraj’s medical team, told ‘cricinfo’. Rohatgi, senior medical oncologist at Delhi’s Max Cancer Centre, said Yuvraj, diagnosed with a mediastinal seminoma, a germ-cell tumour between his lungs, had responded well to therapy.
The doctors’ progressive assessment over the period of almost two months of chemotherapy had indicated that the ‘tumour mass’ detected earlier ‘has now shrunk significantly.
The cancer protein (tumour marker) has come down faster than expected and both the signs together are reassuring of the fact that the cancer should be on the way out of his system.’ Yuvraj has been in the US for treatment since end January. He underwent chemotherapy in Indianapolis at the Indiana University’s IU Simon Cancer Center under the supervision of Rohatgi and Lawrence H Einhorn, who had headed the treatment of cycling champion Lance Armstrong in 1996.